ICON Clinical Research Announces the Appointment of a Vice President and Global Head for the Infectious Diseases Therapeutic Area Group
14 July 2010 | By Weber Shandwick
ICON plc, announced the appointment of...
List view / Grid view
14 July 2010 | By Weber Shandwick
ICON plc, announced the appointment of...
8 July 2010 | By ANDREW LLOYD & ASSOCIATES
Ingen Biosciences, today announced that the company has appointed Dr. Karine Mignon-Godefroy as director of research & development...
8 July 2010 | By College Hill Life Sciences
Phagenesis Limited, a leader in technology for the treatment of stroke patients, has appointed Henry Hyde-Thomson as Chairman and Daniel Green as CEO...
7 July 2010 | By Peter Huber Kältemaschinenbau GmbH
The compact Minichiller® from HUBER reduces water consumption to zero, offering...
5 July 2010 | By kdm communications limited
The Leibniz-Institut für Molekulare Pharmakologie in Berlin, is using Tecan’s Freedom EVO® workstations for systematic high throughput screening of bioactive small molecule libraries...
5 July 2010 | By AstraZeneca
AstraZeneca and MRC Technology, announced a new strategic collaboration to share access to...
2 July 2010 | By NG Online News
The pharmaceutical industry has faced well documented challenges over the last 12 months, such as the Pfizer...
BGMA welcomes EU General Court ruling that AstraZeneca abused its dominant position by preventing the marketing of generic omeprazole.
1 July 2010 | By kdm communications limited
HiTEL Laboratory at the University of York is a service facility offering bespoke protein expression, using a Freedom EVO 200 workstation...
30 June 2010 | By kdm communications limited
Registration for the second annual WIN Symposium on personalized cancer medicine is still open, with a preferential rate available until the 4th of July...
30 June 2010 | By AstraZeneca
AstraZeneca announced today that Judge Joseph Farnan, Jr., US District Court, District of Delaware, has found that the substance patent protecting CRESTOR (RE37,314 – the ‘314 patent) is valid and enforceable...
29 June 2010 | By Velvet Communications Limited
Aesica Pharmaceuticals has today announced that it has successfully acquired leading research and development company R5...
29 June 2010 | By College Hill Ltd
Molecular Partners AG, announced today the appointment of Dr Göran Ando as independent non-executive member of the board of directors...
28 June 2010 | By AstraZeneca
AstraZeneca and Medicines for Malaria Venture (MMV) today announced a collaborative agreement designed to identify novel candidate drugs for the treatment of malaria...
28 June 2010 | By Johnson & Johnson
OMJPI today announced...